Zanubrutinib: its history, current status and ... - CLL Support

CLL Support

23,253 members39,949 posts

Zanubrutinib: its history, current status and ongoing research

5 Replies

You need to be a member of this community to see this post.

Read more about...
5 Replies

You need to be a member of this community to see hidden responses.

Not what you're looking for?

You may also like...

YABTKi or Yet Another BTK inhibitor - the A to Z list of Bruton's Tyrosine Kinase Inhibitors for CLL following Ibrutinib's success

I'll admit that YABTKi is not a recognised CLL related acronym, (acronym lists are here...
AussieNeil profile image
Partner

Second-Generation BTK Inhibitors Hit the Treatment Bullseye With Fewer Off-Target Effects

August 16, 2020 Fewer off-target effects mean second-generation BTK inhibitors offer less...
Jm954 profile image
Administrator

Alterations of the immune system caused by CLL B‐cells

Abstract: Here, we review the current understanding of the underlying interplay between the...

BTK inhibitors for the treatment of CLL - the current state of play of 'brutinibs'

In just a short time, in many places, BTK inhibitors (BTKi) have largely replaced...
CLLerinOz profile image
Administrator

BRUIN Study: phase 1/2 study of Pirtobrutinib (formerly Loxo 305) in relapsed or refractory B-cell malignancies

Patients discontinue BTKi's due to resistance and intolerance. We evaluated the safety and efficacy...
Jm954 profile image
Administrator